Treatment Of Syphilis In Women Research Articles

The diagnosis and treatment of syphilis in women

Syphilis is a sexually transmitted diseage with a known cause and an effective cure. Unfortunately, during the past decade syphilis has resurfaced as a major public health problem. This resurgence of cases has paralleled the rise of crack cocaine abuse and the attendant risky sexual behaviors associated with drug-seeking. Syphilis, as a leading cause of genital ulcer disease, enhances human immunodeficiency virus transmissibility. Syphilis has returned to damage our most vulnerable patients, the developing fetus and newborn. The eradication of this disease awaits the solution of the stubborn social problems of ignorance, poverty, drug abuse, and prostitution.

Postarsenical Encephalopathy in the Treatment of Syphilis in Women

AT LEAST 60 per cent of adults receiving arsenical antisyphilitic therapy who develop postarsenical encephalopathy are pregnant women. The mortality in this most serious complication in the treatment of syphilis approaches 70 per cent. Postarsenical encephalopathy, the term considered most apt, has also been described under the following titles: cerebral purpura, serous apoplexy, hemorrhagic encephalitis, pericapillary encephalorrhagia, medullary perivascular necrosis and toxic encephalitis. There is a widespread lack of familiarity with this cause of death in 1.3 per cent of the total number of patients treated by the massive five-day arsenical course.1 Postarsenical encephalopathy was the cause of 9.5 per . . .